Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
SES AI
SES
$227M
| $234K | ﹤0.01% |
450,000
-215,300
| -32% | -$198K |
|
3027
TScan Therapeutics
TCRX
$52.3M
| $234K | ﹤0.01% |
169,706
+159,106
| +1,501% | +$344K |
|
3028
Enliven Therapeutics
ELVN
$4.25B
| $234K | ﹤0.01% |
+11,900
| New | +$256K |
|
3029
iShares ESG Aware MSCI EM ETF
ESGE
$6.86B
| $234K | ﹤0.01% |
6,700
-72,600
| -92% | -$2.53M |
|
3030
First Financial Bankshares
FFIN
$5.01B
| $233K | ﹤0.01% |
+6,500
| New | +$239K |
|
|
IHT
3031
InnSuites Hospitality Trust
IHT
$15.5M
| $233K | ﹤0.01% |
102,903
-1,300
| -1% | -$3.29K |
|
|
AXIA.PR
3032
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $232K | ﹤0.01% |
37,631
+18,941
| +101% | +$106K |
|
3033
Biodesix
BDSX
$251M
| $232K | ﹤0.01% |
18,535
+525
| +3% | +$10.1K |
|
|
FPAY
3034
DELISTED
FlexShopper
FPAY
| $231K | ﹤0.01% |
180,778
-102,302
| -36% | -$156K |
|
3035
Avalon Holdings
AWX
$10.9M
| $231K | ﹤0.01% |
81,310
+900
| +1% | +$3.02K |
|
3036
Magyar Bancorp
MGYR
$126M
| $231K | ﹤0.01% |
16,586
| – | – |
|
3037
NextCure
NXTC
$37.9M
| $231K | ﹤0.01% |
39,997
-3,278
| -8% | -$28.9K |
|
3038
VirTra
VTSI
$38.1M
| $230K | ﹤0.01% |
56,597
-51,198
| -47% | -$306K |
|
3039
FNB Corp
FNB
$6.86B
| $229K | ﹤0.01% |
17,027
-245,800
| -94% | -$3.61M |
|
3040
Karyopharm Therapeutics
KPTI
$45.1M
| $229K | ﹤0.01% |
61,214
-18,959
| -24% | -$162K |
|
3041
Daxor
DXR
$59.5M
| $228K | ﹤0.01% |
28,121
+300
| +1% | +$2.35K |
|
3042
Regis Corp
RGS
$69.3M
| $228K | ﹤0.01% |
12,546
-6,100
| -33% | -$133K |
|
3043
Standard Motor Products
SMP
$877M
| $227K | ﹤0.01% |
+9,100
| New | +$267K |
|
3044
Cytosorbents Corp
CTSO
$22.8M
| $225K | ﹤0.01% |
225,254
+137,234
| +156% | +$145K |
|
3045
Custom Truck One Source
CTOS
$2.46B
| $225K | ﹤0.01% |
+53,200
| New | +$257K |
|
|
MKFG
3046
DELISTED
Markforged Holding Corporation
MKFG
| $224K | ﹤0.01% |
47,939
+4,300
| +10% | +$13.1K |
|
|
LX
3047
LexinFintech Holdings
LX
$236M
| $224K | ﹤0.01% |
22,200
-243,500
| -92% | -$2.04M |
|
3048
Orange County Bancorp
OBT
$522M
| $222K | ﹤0.01% |
9,500
-2,700
| -22% | -$69.1K |
|
|
KG
3049
Kestrel Group
KG
$66.3M
| $222K | ﹤0.01% |
19,471
-1,175
| -6% | -$22.2K |
|
3050
Inuvo
INUV
$14.2M
| $221K | ﹤0.01% |
62,325
+11,610
| +23% | +$53.1K |
|
Similar funds
Jim Simons's Q1 2025 Portfolio in Review
As of Q1 2025, Jim Simons held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Jim Simons added most to Broadcom in Q1 2025, an estimated $513M increase.
- Jim Simons's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Jim Simons fully exited Nike in Q1 2025, selling an estimated $197M.
- Jim Simons's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Jim Simons opened 456 new positions and closed 583 in Q1 2025.
- Jim Simons's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.